Stay updated on Pyrotinib+Trastuzumab+Docetaxel in HER2+ Metastatic Breast Ca Clinical Trial

Sign up to get notified when there's something new on the Pyrotinib+Trastuzumab+Docetaxel in HER2+ Metastatic Breast Ca Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pyrotinib+Trastuzumab+Docetaxel in HER2+ Metastatic Breast Ca Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The history now shows a new revision tag—v3.6.6—replacing v3.6.5. This indicates a site-wide version update rather than a modification to the study data.
    Difference
    0.1%
    Check dated 2026-09-02T19:52:01.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    A new revision (v3.6.5) was added to the study record history, replacing the previous revision (v3.6.4) in the history log.
    Difference
    0.1%
    Check dated 2026-08-11T19:26:10.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    A new revision entry (v3.6.4) was added to the study record history, replacing the previous v3.6.3 and signaling a minor metadata update.
    Difference
    0.1%
    Check dated 2026-07-21T12:48:43.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    A new revision entry v3.6.3 was added to the study record history, and the older v3.6.0 entry was removed.
    Difference
    0.1%
    Check dated 2026-06-30T01:57:45.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Added 'Last verified' and 'Last known status was' fields to the record history and updated the revision label to 'Revision: v3.6.0' to reflect the latest data verification and versioning.
    Difference
    2%
    Check dated 2026-06-15T19:13:32.000Z thumbnail image
  8. Check
    99 days ago
    Change Detected
    Summary
    The record history shows Revision: v3.5.5 replacing Revision: v3.5.4, indicating a new build/version of the ClinicalTrials.gov history interface.
    Difference
    0.1%
    Check dated 2026-06-08T16:27:21.000Z thumbnail image

Stay in the know with updates to Pyrotinib+Trastuzumab+Docetaxel in HER2+ Metastatic Breast Ca Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pyrotinib+Trastuzumab+Docetaxel in HER2+ Metastatic Breast Ca Clinical Trial page.